Survodutide

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameSurvodutide
Drug Alias NameBI-456906BI-456909
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon receptor
Therapy Area/IndicationsOverweightFibrosisObesity +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[46] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgUniversity Medical Center GroningenBoehringer Ingelheim International Gmbh +[4] 
Inactive CompaniesN/A
Active IndicationsOverweightFibrosisObesity +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A